Biotech Investing Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 13 November
Biotech Investing Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases 05 November
Biotech Investing Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027 21 October
